Does Bariatric Surgery Affect Urinary Incontinence? - 02/09/13

, Michelle J. Semins b, E. James Wright c, Kimberly Steele d, Andrew D. Shore e, Jeanne M. Clark f, Martin A. Makary g, Brian R. Matlaga h, Chi Chiung Grace Chen iAbstract |
Objective |
To determine International Classification of Disease, 9th Revision, (ICD-9) coding patterns as a proxy for incidence and prevalence of urinary incontinence (UI) in a population of patients before and after a bariatric surgical procedure for the treatment of obesity.
Methods |
We evaluated claims from a national private insurer over a 5-year period (2002-2006) to identify female patients who underwent bariatric surgery and had 3 years of follow-up claims data. The cohort of patients who underwent bariatric surgery (treatment) was matched to a cohort of obese female patients who did not undergo bariatric surgery (control), who were followed from the start of their enrollment. UI was identified by ICD-9 coding.
Results |
After bariatric surgery, 62.4% of patients (83/133) diagnosed with UI before their surgery no longer had a coding diagnosis of UI. In contrast, only 42.1% (56/133) of those in the nonbariatric surgery cohort lost their coding diagnosis of UI (P = .0009). Of those that did not have pre-existing UI, 6.2% (235/3765) of the bariatric surgery cohort gained a new coding diagnosis of UI vs 7.1% (269/3765) of the control group (P = .1169). Our final model suggested that age >45 years (P <.0001) and pre-existing UI (P <.0001) were significantly associated with post-index date UI. Interaction between bariatric surgical status and UI was also significant (P <.0001).
Conclusion |
Patients who undergo bariatric surgery are more likely to lose a previous diagnosis of UI than are obese patients not treated with bariatric surgery. This supports the fact that bariatric surgery may have other indirect benefits to the obese population.
Le texte complet de cet article est disponible en PDF.Plan
| Financial Disclosure: The authors declare that they have no relevant financial interests. |
|
| Funding Support: Creation of the database was funded by Ethicon Endo-Surgery, Inc., GlaxoSmithKline, and Pfizer, Inc. Data and support were provided by Blue Cross Blue Shield of Michigan and Highmark. Support was provided by the Blue Cross Blue Shield Association. The supporting organizations were kept informed of the study's progress and shared their expertise on certain aspects of the study. Also, preliminary findings were shared with them and they were invited to review the manuscript. However, they did not have any role in the design and conduct of the study, collection, management, analysis, and interpretation of the data, or preparation or approval of the manuscript. |
Vol 82 - N° 3
P. 547-551 - septembre 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
